Under construction – not a live service
Sign in
Taking people in ThailandPhase 3

Standard HIV Treatment for People With Acute or Chronic HIV Infection

Provides standard antiretroviral HIV treatment to adults with acute or chronic HIV infection.

Plain-language title generated from the registry record
Registry title: Antiretroviral Therapy for Acute and Chronic HIV Infection

Key facts

Where
Bangkok, ThailandSee the site
Phase
Phase 3

Where in Thailand

  • Institute of HIV Research and InnovationBangkok, ThailandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
SEARCH Research Foundation
Trial code
NCT00796263
Record updated
4 June 2025
Original description
The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: 'Establish and characterize an acute HIV infection cohort in a Thai high-risk population') or in a study of chronic HIV infection (SEARCH 013 protocol 'Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais').Read full original descriptionShow less

Antiretroviral Therapy for Acute and Chronic HIV Infection

The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: 'Establish and characterize an acute HIV infection cohort in a Thai high-risk population') or in a study of chronic HIV infection (SEARCH 013 protocol 'Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais').

Inclusion: Age ≥ 18 years old; Enrolled in the SEARCH 010 or 013 protocols with documentation of acute or chronic protocol defined HIV-1 infection and chooses to initiate or continue ART; Understand the study and sign informed consent form. Persons who cannot read will have the consent form read and explained to them by a member of the study staff and they can give informed consent by using their thumb print; Availability for follow-up for the planned study duration.

Exclusion: Persons who have a history of a medical or psychiatric disorder by investigator's interview and physical examination according to standard practices, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.

ClinicalTrials.gov NCT00796263